|
End-of-day quote
Shenzhen S.E.
2026-09-18
|
5-day change | 1st Jan Change | ||
| 5.620 CNY | +0.36% |
|
-0.35% | -23.74% |
| 08-25 | Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 06-01 | Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for 2025 | CI |
ETFs positioned on Beijing SL Pharmaceutical Co., Ltd.
| Name | YTD change | Weight | AuM | |
|---|---|---|---|---|
 | +15.12% | -.--% | 535 M€ | |
| -8.97% | 0.01% | 476 M€ | |
| +11.94% | 0% | 17,649 M€ | |
| +13.13% | 0% | 441 M€ | |
| +15.46% | 0% | 1,190 M€ | |
| +14.24% | 0% | 699 M€ | |
| +14.83% | 0% | 56,205 M€ | |
| +10.14% | 0% | 3,667 M€ | |
| +13.74% | 0% | 3,276 M€ | |
| +3.39% | 0% | 1,449 M€ | |
| +11.63% | 0% | 126,032 M€ | |
| +13.90% | 0% | 2,339 M€ | |
| +11.35% | 0% | 69 M€ | |
| +11.19% | 0% | 27,154 M€ | |
| +7.72% | 0% | 317 M€ | |
| +17.88% | 0% | 117 M€ | |
| +11.42% | 0% | 31 M€ | |
| +13.60% | 0% | 331 M€ | |
| +9.46% | 0% | 81 M€ | |
| +16.07% | 0% | 24 M€ | |
| +13.84% | 0% | 163,510 M€ | |
| +14.00% | 0% | 70,454 M€ | |
| +24.23% | 0% | 82 M€ | |
| +7.89% | 0% | 594 M€ | |
| +15.08% | 0% | 12,086 M€ | |
| +13.38% | 0% | 1,674 M€ | |
| +12.20% | 0% | 19 M€ | |
| +12.40% | 0% | 81,610 M€ | |
| +14.59% | 0% | 2,612 M€ | |
| +7.50% | 0% | 526 M€ | |
| +9.45% | 0% | 391 M€ | |
| +2.48% | 0% | 580 M€ | |
| +7.39% | 0% | 4,204 M€ | |
| +10.88% | 0% | 7,793 M€ | |
| +2.51% | 0% | 59 M€ | |
| -.--% | 0% | 73 M€ | |
| +3.63% | 0% | 363 M€ | |
| +0.63% | 0% | 184 M€ | |
| +1.53% | 0% | 267 M€ | |
| +3.98% | 0% | 688 M€ | |
| +8.99% | 0% | 176 M€ | |
| +13.52% | 0% | 62 M€ | |
| +10.77% | 0% | 513 M€ |
Employees
901
Sector
Pharmaceuticals
- Stock Market
- Stocks
- 002038 Stock
- ETFs Beijing SL Pharmaceutical Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
